nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—SLCO1A2—Conjugated Estrogens—osteoporosis	0.0975	0.169	CbGbCtD
Sumatriptan—SLCO1B1—Conjugated Estrogens—osteoporosis	0.092	0.159	CbGbCtD
Sumatriptan—SLCO1A2—Estradiol—osteoporosis	0.0856	0.148	CbGbCtD
Sumatriptan—SLCO1B1—Estradiol—osteoporosis	0.0807	0.14	CbGbCtD
Sumatriptan—ABCG2—Conjugated Estrogens—osteoporosis	0.0731	0.126	CbGbCtD
Sumatriptan—ABCG2—Estradiol—osteoporosis	0.0641	0.111	CbGbCtD
Sumatriptan—ABCB1—Ethinyl Estradiol—osteoporosis	0.0359	0.0621	CbGbCtD
Sumatriptan—ABCB1—Conjugated Estrogens—osteoporosis	0.0263	0.0455	CbGbCtD
Sumatriptan—ABCB1—Estradiol—osteoporosis	0.0231	0.04	CbGbCtD
Sumatriptan—Melatonin—CYP19A1—osteoporosis	0.00103	0.521	CrCbGaD
Sumatriptan—Melatonin—ESR1—osteoporosis	0.000946	0.479	CrCbGaD
Sumatriptan—Visual impairment—Estradiol—osteoporosis	0.000157	0.000418	CcSEcCtD
Sumatriptan—Chest pain—Zoledronate—osteoporosis	0.000157	0.000417	CcSEcCtD
Sumatriptan—Arthralgia—Zoledronate—osteoporosis	0.000157	0.000417	CcSEcCtD
Sumatriptan—Myalgia—Zoledronate—osteoporosis	0.000157	0.000417	CcSEcCtD
Sumatriptan—Palpitations—Conjugated Estrogens—osteoporosis	0.000157	0.000417	CcSEcCtD
Sumatriptan—Anxiety—Zoledronate—osteoporosis	0.000156	0.000416	CcSEcCtD
Sumatriptan—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000156	0.000415	CcSEcCtD
Sumatriptan—Paraesthesia—Risedronate—osteoporosis	0.000155	0.000414	CcSEcCtD
Sumatriptan—Pruritus—Estropipate—osteoporosis	0.000155	0.000413	CcSEcCtD
Sumatriptan—Discomfort—Zoledronate—osteoporosis	0.000155	0.000412	CcSEcCtD
Sumatriptan—Asthenia—Alendronate—osteoporosis	0.000155	0.000412	CcSEcCtD
Sumatriptan—Hypersensitivity—Ibandronate—osteoporosis	0.000155	0.000412	CcSEcCtD
Sumatriptan—Cough—Conjugated Estrogens—osteoporosis	0.000155	0.000412	CcSEcCtD
Sumatriptan—Dyspnoea—Risedronate—osteoporosis	0.000154	0.000411	CcSEcCtD
Sumatriptan—Hypotension—Pamidronate—osteoporosis	0.000154	0.000409	CcSEcCtD
Sumatriptan—Convulsion—Conjugated Estrogens—osteoporosis	0.000154	0.000409	CcSEcCtD
Sumatriptan—Dry mouth—Zoledronate—osteoporosis	0.000153	0.000408	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000153	0.000408	CcSEcCtD
Sumatriptan—Fatigue—Ethinyl Estradiol—osteoporosis	0.000153	0.000407	CcSEcCtD
Sumatriptan—Pruritus—Alendronate—osteoporosis	0.000153	0.000406	CcSEcCtD
Sumatriptan—Eye disorder—Estradiol—osteoporosis	0.000152	0.000406	CcSEcCtD
Sumatriptan—Tinnitus—Estradiol—osteoporosis	0.000152	0.000405	CcSEcCtD
Sumatriptan—Constipation—Ethinyl Estradiol—osteoporosis	0.000152	0.000404	CcSEcCtD
Sumatriptan—Confusional state—Zoledronate—osteoporosis	0.000152	0.000403	CcSEcCtD
Sumatriptan—Hypersensitivity—Calcitriol—osteoporosis	0.000151	0.000403	CcSEcCtD
Sumatriptan—Flushing—Estradiol—osteoporosis	0.000151	0.000403	CcSEcCtD
Sumatriptan—Arthralgia—Conjugated Estrogens—osteoporosis	0.000151	0.000402	CcSEcCtD
Sumatriptan—Chest pain—Conjugated Estrogens—osteoporosis	0.000151	0.000402	CcSEcCtD
Sumatriptan—Myalgia—Conjugated Estrogens—osteoporosis	0.000151	0.000402	CcSEcCtD
Sumatriptan—Asthenia—Ibandronate—osteoporosis	0.000151	0.000401	CcSEcCtD
Sumatriptan—Anxiety—Conjugated Estrogens—osteoporosis	0.00015	0.0004	CcSEcCtD
Sumatriptan—Nausea—Etidronic acid—osteoporosis	0.00015	0.0004	CcSEcCtD
Sumatriptan—Anaphylactic shock—Zoledronate—osteoporosis	0.00015	0.0004	CcSEcCtD
Sumatriptan—Oedema—Zoledronate—osteoporosis	0.00015	0.0004	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00015	0.000399	CcSEcCtD
Sumatriptan—Diarrhoea—Estropipate—osteoporosis	0.00015	0.000399	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Risedronate—osteoporosis	0.000149	0.000398	CcSEcCtD
Sumatriptan—Infection—Zoledronate—osteoporosis	0.000149	0.000397	CcSEcCtD
Sumatriptan—Fatigue—Risedronate—osteoporosis	0.000149	0.000397	CcSEcCtD
Sumatriptan—Pruritus—Ibandronate—osteoporosis	0.000149	0.000396	CcSEcCtD
Sumatriptan—Pain—Risedronate—osteoporosis	0.000148	0.000394	CcSEcCtD
Sumatriptan—Constipation—Risedronate—osteoporosis	0.000148	0.000394	CcSEcCtD
Sumatriptan—Angiopathy—Estradiol—osteoporosis	0.000148	0.000394	CcSEcCtD
Sumatriptan—Shock—Zoledronate—osteoporosis	0.000148	0.000394	CcSEcCtD
Sumatriptan—Paraesthesia—Pamidronate—osteoporosis	0.000148	0.000393	CcSEcCtD
Sumatriptan—Diarrhoea—Alendronate—osteoporosis	0.000148	0.000393	CcSEcCtD
Sumatriptan—Asthenia—Calcitriol—osteoporosis	0.000148	0.000393	CcSEcCtD
Sumatriptan—Nervous system disorder—Zoledronate—osteoporosis	0.000147	0.000392	CcSEcCtD
Sumatriptan—Immune system disorder—Estradiol—osteoporosis	0.000147	0.000392	CcSEcCtD
Sumatriptan—Thrombocytopenia—Zoledronate—osteoporosis	0.000147	0.000392	CcSEcCtD
Sumatriptan—Mediastinal disorder—Estradiol—osteoporosis	0.000147	0.000391	CcSEcCtD
Sumatriptan—Dyspnoea—Pamidronate—osteoporosis	0.000147	0.000391	CcSEcCtD
Sumatriptan—Tachycardia—Zoledronate—osteoporosis	0.000147	0.00039	CcSEcCtD
Sumatriptan—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000146	0.000389	CcSEcCtD
Sumatriptan—Chills—Estradiol—osteoporosis	0.000146	0.000389	CcSEcCtD
Sumatriptan—Somnolence—Pamidronate—osteoporosis	0.000146	0.000389	CcSEcCtD
Sumatriptan—Skin disorder—Zoledronate—osteoporosis	0.000146	0.000389	CcSEcCtD
Sumatriptan—Pruritus—Calcitriol—osteoporosis	0.000145	0.000387	CcSEcCtD
Sumatriptan—Hyperhidrosis—Zoledronate—osteoporosis	0.000145	0.000387	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000145	0.000386	CcSEcCtD
Sumatriptan—Diarrhoea—Raloxifene—osteoporosis	0.000145	0.000386	CcSEcCtD
Sumatriptan—Dizziness—Estropipate—osteoporosis	0.000145	0.000386	CcSEcCtD
Sumatriptan—Oedema—Conjugated Estrogens—osteoporosis	0.000145	0.000385	CcSEcCtD
Sumatriptan—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000145	0.000385	CcSEcCtD
Sumatriptan—Infection—Conjugated Estrogens—osteoporosis	0.000144	0.000383	CcSEcCtD
Sumatriptan—Diarrhoea—Ibandronate—osteoporosis	0.000144	0.000383	CcSEcCtD
Sumatriptan—Decreased appetite—Pamidronate—osteoporosis	0.000143	0.000381	CcSEcCtD
Sumatriptan—Dizziness—Alendronate—osteoporosis	0.000143	0.00038	CcSEcCtD
Sumatriptan—Shock—Conjugated Estrogens—osteoporosis	0.000142	0.000379	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000142	0.000378	CcSEcCtD
Sumatriptan—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000142	0.000378	CcSEcCtD
Sumatriptan—Erythema—Estradiol—osteoporosis	0.000142	0.000378	CcSEcCtD
Sumatriptan—Fatigue—Pamidronate—osteoporosis	0.000142	0.000378	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Risedronate—osteoporosis	0.000142	0.000377	CcSEcCtD
Sumatriptan—Tachycardia—Conjugated Estrogens—osteoporosis	0.000141	0.000376	CcSEcCtD
Sumatriptan—Urticaria—Ethinyl Estradiol—osteoporosis	0.000141	0.000375	CcSEcCtD
Sumatriptan—Pain—Pamidronate—osteoporosis	0.000141	0.000375	CcSEcCtD
Sumatriptan—Constipation—Pamidronate—osteoporosis	0.000141	0.000375	CcSEcCtD
Sumatriptan—Diarrhoea—Calcitriol—osteoporosis	0.000141	0.000374	CcSEcCtD
Sumatriptan—Skin disorder—Conjugated Estrogens—osteoporosis	0.000141	0.000374	CcSEcCtD
Sumatriptan—Hypotension—Zoledronate—osteoporosis	0.00014	0.000374	CcSEcCtD
Sumatriptan—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00014	0.000374	CcSEcCtD
Sumatriptan—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00014	0.000374	CcSEcCtD
Sumatriptan—Dizziness—Raloxifene—osteoporosis	0.00014	0.000373	CcSEcCtD
Sumatriptan—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00014	0.000372	CcSEcCtD
Sumatriptan—Flatulence—Estradiol—osteoporosis	0.00014	0.000372	CcSEcCtD
Sumatriptan—Vomiting—Estropipate—osteoporosis	0.000139	0.000371	CcSEcCtD
Sumatriptan—Dysgeusia—Estradiol—osteoporosis	0.000139	0.00037	CcSEcCtD
Sumatriptan—Dizziness—Ibandronate—osteoporosis	0.000139	0.00037	CcSEcCtD
Sumatriptan—Rash—Estropipate—osteoporosis	0.000138	0.000368	CcSEcCtD
Sumatriptan—Dermatitis—Estropipate—osteoporosis	0.000138	0.000367	CcSEcCtD
Sumatriptan—Urticaria—Risedronate—osteoporosis	0.000138	0.000366	CcSEcCtD
Sumatriptan—Back pain—Estradiol—osteoporosis	0.000137	0.000365	CcSEcCtD
Sumatriptan—Headache—Estropipate—osteoporosis	0.000137	0.000365	CcSEcCtD
Sumatriptan—Vomiting—Alendronate—osteoporosis	0.000137	0.000365	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000137	0.000365	CcSEcCtD
Sumatriptan—Body temperature increased—Risedronate—osteoporosis	0.000137	0.000364	CcSEcCtD
Sumatriptan—Abdominal pain—Risedronate—osteoporosis	0.000137	0.000364	CcSEcCtD
Sumatriptan—Muscle spasms—Estradiol—osteoporosis	0.000136	0.000363	CcSEcCtD
Sumatriptan—Rash—Alendronate—osteoporosis	0.000136	0.000362	CcSEcCtD
Sumatriptan—Dermatitis—Alendronate—osteoporosis	0.000136	0.000362	CcSEcCtD
Sumatriptan—Feeling abnormal—Pamidronate—osteoporosis	0.000136	0.000361	CcSEcCtD
Sumatriptan—Hypotension—Conjugated Estrogens—osteoporosis	0.000135	0.00036	CcSEcCtD
Sumatriptan—Headache—Alendronate—osteoporosis	0.000135	0.00036	CcSEcCtD
Sumatriptan—Paraesthesia—Zoledronate—osteoporosis	0.000135	0.000359	CcSEcCtD
Sumatriptan—Vomiting—Raloxifene—osteoporosis	0.000135	0.000359	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Pamidronate—osteoporosis	0.000135	0.000358	CcSEcCtD
Sumatriptan—Dyspnoea—Zoledronate—osteoporosis	0.000134	0.000357	CcSEcCtD
Sumatriptan—Rash—Raloxifene—osteoporosis	0.000134	0.000356	CcSEcCtD
Sumatriptan—Dermatitis—Raloxifene—osteoporosis	0.000134	0.000356	CcSEcCtD
Sumatriptan—Somnolence—Zoledronate—osteoporosis	0.000134	0.000356	CcSEcCtD
Sumatriptan—Vomiting—Ibandronate—osteoporosis	0.000134	0.000355	CcSEcCtD
Sumatriptan—Tremor—Estradiol—osteoporosis	0.000133	0.000354	CcSEcCtD
Sumatriptan—Headache—Raloxifene—osteoporosis	0.000133	0.000354	CcSEcCtD
Sumatriptan—Rash—Ibandronate—osteoporosis	0.000132	0.000353	CcSEcCtD
Sumatriptan—Dermatitis—Ibandronate—osteoporosis	0.000132	0.000352	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000132	0.000351	CcSEcCtD
Sumatriptan—Ill-defined disorder—Estradiol—osteoporosis	0.000132	0.000351	CcSEcCtD
Sumatriptan—Headache—Ibandronate—osteoporosis	0.000132	0.00035	CcSEcCtD
Sumatriptan—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000131	0.000348	CcSEcCtD
Sumatriptan—Vomiting—Calcitriol—osteoporosis	0.000131	0.000348	CcSEcCtD
Sumatriptan—Decreased appetite—Zoledronate—osteoporosis	0.000131	0.000348	CcSEcCtD
Sumatriptan—Agitation—Estradiol—osteoporosis	0.00013	0.000347	CcSEcCtD
Sumatriptan—Nausea—Estropipate—osteoporosis	0.00013	0.000346	CcSEcCtD
Sumatriptan—Abdominal pain—Pamidronate—osteoporosis	0.00013	0.000346	CcSEcCtD
Sumatriptan—Body temperature increased—Pamidronate—osteoporosis	0.00013	0.000346	CcSEcCtD
Sumatriptan—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00013	0.000346	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00013	0.000345	CcSEcCtD
Sumatriptan—Angioedema—Estradiol—osteoporosis	0.00013	0.000345	CcSEcCtD
Sumatriptan—Rash—Calcitriol—osteoporosis	0.00013	0.000345	CcSEcCtD
Sumatriptan—Fatigue—Zoledronate—osteoporosis	0.00013	0.000345	CcSEcCtD
Sumatriptan—Dermatitis—Calcitriol—osteoporosis	0.00013	0.000345	CcSEcCtD
Sumatriptan—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000129	0.000343	CcSEcCtD
Sumatriptan—Headache—Calcitriol—osteoporosis	0.000129	0.000343	CcSEcCtD
Sumatriptan—Somnolence—Conjugated Estrogens—osteoporosis	0.000129	0.000342	CcSEcCtD
Sumatriptan—Pain—Zoledronate—osteoporosis	0.000129	0.000342	CcSEcCtD
Sumatriptan—Constipation—Zoledronate—osteoporosis	0.000129	0.000342	CcSEcCtD
Sumatriptan—Nausea—Alendronate—osteoporosis	0.000128	0.000341	CcSEcCtD
Sumatriptan—Malaise—Estradiol—osteoporosis	0.000128	0.000341	CcSEcCtD
Sumatriptan—Hypersensitivity—Risedronate—osteoporosis	0.000128	0.000339	CcSEcCtD
Sumatriptan—Vertigo—Estradiol—osteoporosis	0.000128	0.000339	CcSEcCtD
Sumatriptan—Asthenia—Ethinyl Estradiol—osteoporosis	0.000127	0.000339	CcSEcCtD
Sumatriptan—Syncope—Estradiol—osteoporosis	0.000127	0.000339	CcSEcCtD
Sumatriptan—Nausea—Raloxifene—osteoporosis	0.000126	0.000335	CcSEcCtD
Sumatriptan—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000126	0.000335	CcSEcCtD
Sumatriptan—Pruritus—Ethinyl Estradiol—osteoporosis	0.000126	0.000334	CcSEcCtD
Sumatriptan—Palpitations—Estradiol—osteoporosis	0.000125	0.000334	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000125	0.000333	CcSEcCtD
Sumatriptan—Fatigue—Conjugated Estrogens—osteoporosis	0.000125	0.000332	CcSEcCtD
Sumatriptan—Nausea—Ibandronate—osteoporosis	0.000125	0.000332	CcSEcCtD
Sumatriptan—Loss of consciousness—Estradiol—osteoporosis	0.000125	0.000332	CcSEcCtD
Sumatriptan—Asthenia—Risedronate—osteoporosis	0.000124	0.000331	CcSEcCtD
Sumatriptan—Feeling abnormal—Zoledronate—osteoporosis	0.000124	0.00033	CcSEcCtD
Sumatriptan—Cough—Estradiol—osteoporosis	0.000124	0.00033	CcSEcCtD
Sumatriptan—Pain—Conjugated Estrogens—osteoporosis	0.000124	0.000329	CcSEcCtD
Sumatriptan—Constipation—Conjugated Estrogens—osteoporosis	0.000124	0.000329	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Zoledronate—osteoporosis	0.000123	0.000327	CcSEcCtD
Sumatriptan—Hypertension—Estradiol—osteoporosis	0.000123	0.000326	CcSEcCtD
Sumatriptan—Pruritus—Risedronate—osteoporosis	0.000122	0.000326	CcSEcCtD
Sumatriptan—Nausea—Calcitriol—osteoporosis	0.000122	0.000325	CcSEcCtD
Sumatriptan—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000121	0.000323	CcSEcCtD
Sumatriptan—Hypersensitivity—Pamidronate—osteoporosis	0.000121	0.000323	CcSEcCtD
Sumatriptan—Myalgia—Estradiol—osteoporosis	0.000121	0.000322	CcSEcCtD
Sumatriptan—Arthralgia—Estradiol—osteoporosis	0.000121	0.000322	CcSEcCtD
Sumatriptan—Chest pain—Estradiol—osteoporosis	0.000121	0.000322	CcSEcCtD
Sumatriptan—Anxiety—Estradiol—osteoporosis	0.00012	0.000321	CcSEcCtD
Sumatriptan—Urticaria—Zoledronate—osteoporosis	0.000119	0.000318	CcSEcCtD
Sumatriptan—Discomfort—Estradiol—osteoporosis	0.000119	0.000318	CcSEcCtD
Sumatriptan—Body temperature increased—Zoledronate—osteoporosis	0.000119	0.000316	CcSEcCtD
Sumatriptan—Abdominal pain—Zoledronate—osteoporosis	0.000119	0.000316	CcSEcCtD
Sumatriptan—Diarrhoea—Risedronate—osteoporosis	0.000118	0.000315	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000118	0.000315	CcSEcCtD
Sumatriptan—Dry mouth—Estradiol—osteoporosis	0.000118	0.000315	CcSEcCtD
Sumatriptan—Asthenia—Pamidronate—osteoporosis	0.000118	0.000314	CcSEcCtD
Sumatriptan—Dizziness—Ethinyl Estradiol—osteoporosis	0.000117	0.000313	CcSEcCtD
Sumatriptan—Confusional state—Estradiol—osteoporosis	0.000117	0.000311	CcSEcCtD
Sumatriptan—Pruritus—Pamidronate—osteoporosis	0.000116	0.00031	CcSEcCtD
Sumatriptan—Oedema—Estradiol—osteoporosis	0.000116	0.000308	CcSEcCtD
Sumatriptan—Anaphylactic shock—Estradiol—osteoporosis	0.000116	0.000308	CcSEcCtD
Sumatriptan—Infection—Estradiol—osteoporosis	0.000115	0.000306	CcSEcCtD
Sumatriptan—Urticaria—Conjugated Estrogens—osteoporosis	0.000115	0.000306	CcSEcCtD
Sumatriptan—Dizziness—Risedronate—osteoporosis	0.000114	0.000305	CcSEcCtD
Sumatriptan—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000114	0.000305	CcSEcCtD
Sumatriptan—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000114	0.000305	CcSEcCtD
Sumatriptan—Shock—Estradiol—osteoporosis	0.000114	0.000303	CcSEcCtD
Sumatriptan—Nervous system disorder—Estradiol—osteoporosis	0.000114	0.000302	CcSEcCtD
Sumatriptan—Tachycardia—Estradiol—osteoporosis	0.000113	0.000301	CcSEcCtD
Sumatriptan—Vomiting—Ethinyl Estradiol—osteoporosis	0.000113	0.0003	CcSEcCtD
Sumatriptan—Diarrhoea—Pamidronate—osteoporosis	0.000113	0.0003	CcSEcCtD
Sumatriptan—Skin disorder—Estradiol—osteoporosis	0.000113	0.000299	CcSEcCtD
Sumatriptan—Hyperhidrosis—Estradiol—osteoporosis	0.000112	0.000298	CcSEcCtD
Sumatriptan—Rash—Ethinyl Estradiol—osteoporosis	0.000112	0.000298	CcSEcCtD
Sumatriptan—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000112	0.000298	CcSEcCtD
Sumatriptan—Headache—Ethinyl Estradiol—osteoporosis	0.000111	0.000296	CcSEcCtD
Sumatriptan—Hypersensitivity—Zoledronate—osteoporosis	0.000111	0.000295	CcSEcCtD
Sumatriptan—Vomiting—Risedronate—osteoporosis	0.00011	0.000293	CcSEcCtD
Sumatriptan—Rash—Risedronate—osteoporosis	0.000109	0.000291	CcSEcCtD
Sumatriptan—Dermatitis—Risedronate—osteoporosis	0.000109	0.00029	CcSEcCtD
Sumatriptan—Dizziness—Pamidronate—osteoporosis	0.000109	0.00029	CcSEcCtD
Sumatriptan—Headache—Risedronate—osteoporosis	0.000108	0.000289	CcSEcCtD
Sumatriptan—Asthenia—Zoledronate—osteoporosis	0.000108	0.000287	CcSEcCtD
Sumatriptan—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000107	0.000284	CcSEcCtD
Sumatriptan—Pruritus—Zoledronate—osteoporosis	0.000106	0.000283	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000106	0.000281	CcSEcCtD
Sumatriptan—Nausea—Ethinyl Estradiol—osteoporosis	0.000105	0.000281	CcSEcCtD
Sumatriptan—Vomiting—Pamidronate—osteoporosis	0.000105	0.000279	CcSEcCtD
Sumatriptan—Paraesthesia—Estradiol—osteoporosis	0.000104	0.000277	CcSEcCtD
Sumatriptan—Asthenia—Conjugated Estrogens—osteoporosis	0.000104	0.000276	CcSEcCtD
Sumatriptan—Rash—Pamidronate—osteoporosis	0.000104	0.000276	CcSEcCtD
Sumatriptan—Dermatitis—Pamidronate—osteoporosis	0.000104	0.000276	CcSEcCtD
Sumatriptan—Dyspnoea—Estradiol—osteoporosis	0.000103	0.000275	CcSEcCtD
Sumatriptan—Headache—Pamidronate—osteoporosis	0.000103	0.000274	CcSEcCtD
Sumatriptan—Somnolence—Estradiol—osteoporosis	0.000103	0.000274	CcSEcCtD
Sumatriptan—Diarrhoea—Zoledronate—osteoporosis	0.000103	0.000274	CcSEcCtD
Sumatriptan—Nausea—Risedronate—osteoporosis	0.000103	0.000274	CcSEcCtD
Sumatriptan—Pruritus—Conjugated Estrogens—osteoporosis	0.000102	0.000273	CcSEcCtD
Sumatriptan—Decreased appetite—Estradiol—osteoporosis	0.000101	0.000268	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Estradiol—osteoporosis	0.0001	0.000266	CcSEcCtD
Sumatriptan—Fatigue—Estradiol—osteoporosis	9.99e-05	0.000266	CcSEcCtD
Sumatriptan—Dizziness—Zoledronate—osteoporosis	9.94e-05	0.000265	CcSEcCtD
Sumatriptan—Pain—Estradiol—osteoporosis	9.9e-05	0.000264	CcSEcCtD
Sumatriptan—Constipation—Estradiol—osteoporosis	9.9e-05	0.000264	CcSEcCtD
Sumatriptan—Diarrhoea—Conjugated Estrogens—osteoporosis	9.9e-05	0.000264	CcSEcCtD
Sumatriptan—Nausea—Pamidronate—osteoporosis	9.77e-05	0.00026	CcSEcCtD
Sumatriptan—Dizziness—Conjugated Estrogens—osteoporosis	9.57e-05	0.000255	CcSEcCtD
Sumatriptan—Vomiting—Zoledronate—osteoporosis	9.56e-05	0.000254	CcSEcCtD
Sumatriptan—Feeling abnormal—Estradiol—osteoporosis	9.54e-05	0.000254	CcSEcCtD
Sumatriptan—Rash—Zoledronate—osteoporosis	9.48e-05	0.000252	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Estradiol—osteoporosis	9.47e-05	0.000252	CcSEcCtD
Sumatriptan—Dermatitis—Zoledronate—osteoporosis	9.47e-05	0.000252	CcSEcCtD
Sumatriptan—Headache—Zoledronate—osteoporosis	9.42e-05	0.000251	CcSEcCtD
Sumatriptan—Vomiting—Conjugated Estrogens—osteoporosis	9.2e-05	0.000245	CcSEcCtD
Sumatriptan—Urticaria—Estradiol—osteoporosis	9.2e-05	0.000245	CcSEcCtD
Sumatriptan—Abdominal pain—Estradiol—osteoporosis	9.16e-05	0.000244	CcSEcCtD
Sumatriptan—Body temperature increased—Estradiol—osteoporosis	9.16e-05	0.000244	CcSEcCtD
Sumatriptan—Rash—Conjugated Estrogens—osteoporosis	9.12e-05	0.000243	CcSEcCtD
Sumatriptan—Dermatitis—Conjugated Estrogens—osteoporosis	9.12e-05	0.000243	CcSEcCtD
Sumatriptan—Headache—Conjugated Estrogens—osteoporosis	9.07e-05	0.000241	CcSEcCtD
Sumatriptan—Nausea—Zoledronate—osteoporosis	8.93e-05	0.000238	CcSEcCtD
Sumatriptan—Nausea—Conjugated Estrogens—osteoporosis	8.6e-05	0.000229	CcSEcCtD
Sumatriptan—Hypersensitivity—Estradiol—osteoporosis	8.53e-05	0.000227	CcSEcCtD
Sumatriptan—Asthenia—Estradiol—osteoporosis	8.31e-05	0.000221	CcSEcCtD
Sumatriptan—Pruritus—Estradiol—osteoporosis	8.19e-05	0.000218	CcSEcCtD
Sumatriptan—Diarrhoea—Estradiol—osteoporosis	7.92e-05	0.000211	CcSEcCtD
Sumatriptan—Dizziness—Estradiol—osteoporosis	7.66e-05	0.000204	CcSEcCtD
Sumatriptan—Vomiting—Estradiol—osteoporosis	7.36e-05	0.000196	CcSEcCtD
Sumatriptan—Rash—Estradiol—osteoporosis	7.3e-05	0.000194	CcSEcCtD
Sumatriptan—Dermatitis—Estradiol—osteoporosis	7.3e-05	0.000194	CcSEcCtD
Sumatriptan—Headache—Estradiol—osteoporosis	7.26e-05	0.000193	CcSEcCtD
Sumatriptan—Nausea—Estradiol—osteoporosis	6.88e-05	0.000183	CcSEcCtD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	3.7e-05	0.000838	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—LRP5—osteoporosis	3.68e-05	0.000835	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—IL6—osteoporosis	3.68e-05	0.000834	CbGpPWpGaD
Sumatriptan—ABCB1—Allograft Rejection—TNF—osteoporosis	3.63e-05	0.000823	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CYP27A1—osteoporosis	3.62e-05	0.000822	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	3.62e-05	0.000821	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CNR2—osteoporosis	3.61e-05	0.000819	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—P4HB—osteoporosis	3.61e-05	0.000818	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.59e-05	0.000813	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—TPI1—osteoporosis	3.54e-05	0.000803	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GAPDH—osteoporosis	3.54e-05	0.000803	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ACP5—osteoporosis	3.53e-05	0.000799	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—LRP6—osteoporosis	3.52e-05	0.000798	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PTHLH—osteoporosis	3.5e-05	0.000793	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—KL—osteoporosis	3.46e-05	0.000785	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—RAP1A—osteoporosis	3.45e-05	0.000782	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—P4HB—osteoporosis	3.44e-05	0.000779	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PKM—osteoporosis	3.41e-05	0.000774	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—FDPS—osteoporosis	3.41e-05	0.000774	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—WNT1—osteoporosis	3.4e-05	0.00077	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CALCA—osteoporosis	3.39e-05	0.000769	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PTHLH—osteoporosis	3.38e-05	0.000767	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—POMC—osteoporosis	3.38e-05	0.000766	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—P4HB—osteoporosis	3.37e-05	0.000763	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PTH—osteoporosis	3.34e-05	0.000758	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—P4HB—osteoporosis	3.33e-05	0.000755	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.32e-05	0.000753	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MGLL—osteoporosis	3.31e-05	0.000751	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—IL6R—osteoporosis	3.3e-05	0.000747	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RAP1A—osteoporosis	3.29e-05	0.000745	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—TPI1—osteoporosis	3.28e-05	0.000743	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PTH—osteoporosis	3.27e-05	0.000742	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GAPDH—osteoporosis	3.27e-05	0.000741	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CNR2—osteoporosis	3.26e-05	0.000739	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.25e-05	0.000736	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GPD2—osteoporosis	3.23e-05	0.000733	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PGLS—osteoporosis	3.23e-05	0.000733	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—ADCY5—osteoporosis	3.23e-05	0.000733	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—LRP5—osteoporosis	3.23e-05	0.000733	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RAP1A—osteoporosis	3.22e-05	0.000729	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NFATC1—osteoporosis	3.21e-05	0.000727	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	3.2e-05	0.000726	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CNR2—osteoporosis	3.19e-05	0.000723	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—RAP1A—osteoporosis	3.18e-05	0.000722	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—DKK1—osteoporosis	3.18e-05	0.000721	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—ADCY5—osteoporosis	3.17e-05	0.000718	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—POMC—osteoporosis	3.14e-05	0.000712	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NFATC1—osteoporosis	3.14e-05	0.000712	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—osteoporosis	3.13e-05	0.000709	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—DKK1—osteoporosis	3.11e-05	0.000706	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—LRP6—osteoporosis	3.09e-05	0.000701	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—P4HB—osteoporosis	3.08e-05	0.000699	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CALCA—osteoporosis	3.08e-05	0.000698	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PTHLH—osteoporosis	3.07e-05	0.000696	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—WNT1—osteoporosis	3.06e-05	0.000695	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GAPDH—osteoporosis	3.03e-05	0.000686	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ENO1—osteoporosis	3.01e-05	0.000682	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—WNT1—osteoporosis	3e-05	0.00068	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—FGA—osteoporosis	2.98e-05	0.000676	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CALCA—osteoporosis	2.98e-05	0.000675	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TLN1—osteoporosis	2.97e-05	0.000674	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PSMA2—osteoporosis	2.96e-05	0.000672	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PSMA5—osteoporosis	2.96e-05	0.000672	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ATIC—osteoporosis	2.96e-05	0.000671	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PNP—osteoporosis	2.96e-05	0.000671	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—RAP1A—osteoporosis	2.95e-05	0.000668	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—ADCY5—osteoporosis	2.94e-05	0.000666	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—FGA—osteoporosis	2.92e-05	0.000662	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—ADCY5—osteoporosis	2.88e-05	0.000652	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ENO1—osteoporosis	2.79e-05	0.000632	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.77e-05	0.000629	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PTHLH—osteoporosis	2.77e-05	0.000628	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—BMP2—osteoporosis	2.77e-05	0.000628	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—POMC—osteoporosis	2.76e-05	0.000625	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PSMA2—osteoporosis	2.75e-05	0.000623	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PSMA5—osteoporosis	2.75e-05	0.000623	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—ADCY5—osteoporosis	2.71e-05	0.000615	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PTHLH—osteoporosis	2.71e-05	0.000615	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—BMP2—osteoporosis	2.71e-05	0.000615	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—FGB—osteoporosis	2.71e-05	0.000615	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CALCA—osteoporosis	2.7e-05	0.000613	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—FGB—osteoporosis	2.65e-05	0.000602	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—SPP1—osteoporosis	2.62e-05	0.000595	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PSMA5—osteoporosis	2.62e-05	0.000593	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PSMA2—osteoporosis	2.62e-05	0.000593	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TLN1—osteoporosis	2.61e-05	0.000592	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ENO1—osteoporosis	2.57e-05	0.000583	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—P4HB—osteoporosis	2.56e-05	0.000581	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PSMA2—osteoporosis	2.56e-05	0.000581	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PSMA5—osteoporosis	2.56e-05	0.000581	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PSMA2—osteoporosis	2.53e-05	0.000575	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PSMA5—osteoporosis	2.53e-05	0.000575	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—OXCT1—osteoporosis	2.52e-05	0.00057	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CA2—osteoporosis	2.52e-05	0.00057	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PTH—osteoporosis	2.49e-05	0.000565	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MGLL—osteoporosis	2.45e-05	0.000556	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RAP1A—osteoporosis	2.45e-05	0.000556	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CALCA—osteoporosis	2.44e-05	0.000553	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CNR2—osteoporosis	2.43e-05	0.000551	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—ADCY5—osteoporosis	2.41e-05	0.000547	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CYP19A1—osteoporosis	2.4e-05	0.000545	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NFATC1—osteoporosis	2.39e-05	0.000542	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CALCA—osteoporosis	2.39e-05	0.000542	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ENO1—osteoporosis	2.38e-05	0.00054	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—POMC—osteoporosis	2.38e-05	0.000539	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IRS2—osteoporosis	2.37e-05	0.000538	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—DKK1—osteoporosis	2.37e-05	0.000538	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PSMA5—osteoporosis	2.35e-05	0.000532	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PSMA2—osteoporosis	2.35e-05	0.000532	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—POMC—osteoporosis	2.33e-05	0.000528	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—LEP—osteoporosis	2.32e-05	0.000527	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—WNT1—osteoporosis	2.28e-05	0.000518	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—P4HB—osteoporosis	2.25e-05	0.00051	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—IL6—osteoporosis	2.24e-05	0.000508	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CYP19A1—osteoporosis	2.23e-05	0.000505	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FGA—osteoporosis	2.22e-05	0.000504	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—ESR1—osteoporosis	2.22e-05	0.000503	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KL—osteoporosis	2.21e-05	0.000502	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—ADCY5—osteoporosis	2.19e-05	0.000497	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTH—osteoporosis	2.19e-05	0.000496	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KL—osteoporosis	2.17e-05	0.000492	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—POMC—osteoporosis	2.16e-05	0.00049	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RAP1A—osteoporosis	2.15e-05	0.000488	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CNR2—osteoporosis	2.13e-05	0.000484	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—ADCY5—osteoporosis	2.12e-05	0.00048	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—POMC—osteoporosis	2.12e-05	0.00048	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL6R—osteoporosis	2.11e-05	0.000478	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NFATC1—osteoporosis	2.1e-05	0.000476	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—IDH2—osteoporosis	2.08e-05	0.000473	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—DKK1—osteoporosis	2.08e-05	0.000472	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IRS1—osteoporosis	2.07e-05	0.00047	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PTHLH—osteoporosis	2.07e-05	0.000469	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—BMP2—osteoporosis	2.07e-05	0.000469	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL6R—osteoporosis	2.06e-05	0.000468	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CYP19A1—osteoporosis	2.06e-05	0.000466	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FGB—osteoporosis	2.02e-05	0.000459	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—WNT1—osteoporosis	2.01e-05	0.000455	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—POMC—osteoporosis	2e-05	0.000452	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ADCY5—osteoporosis	1.96e-05	0.000446	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP27A1—osteoporosis	1.96e-05	0.000444	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GPX1—osteoporosis	1.96e-05	0.000444	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PSMA2—osteoporosis	1.95e-05	0.000443	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PSMA5—osteoporosis	1.95e-05	0.000443	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FGA—osteoporosis	1.95e-05	0.000443	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL6R—osteoporosis	1.95e-05	0.000441	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—ADCY5—osteoporosis	1.92e-05	0.000436	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.92e-05	0.000436	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IGF1—osteoporosis	1.92e-05	0.000435	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.92e-05	0.000435	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ACP5—osteoporosis	1.91e-05	0.000432	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CYP19A1—osteoporosis	1.9e-05	0.000432	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ADCY5—osteoporosis	1.82e-05	0.000413	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CALCA—osteoporosis	1.82e-05	0.000413	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GPX1—osteoporosis	1.81e-05	0.000411	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—BMP2—osteoporosis	1.81e-05	0.000411	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTHLH—osteoporosis	1.81e-05	0.000411	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—MTHFR—osteoporosis	1.81e-05	0.00041	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.8e-05	0.000407	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.79e-05	0.000406	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FGB—osteoporosis	1.78e-05	0.000403	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—POMC—osteoporosis	1.77e-05	0.000402	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—TPI1—osteoporosis	1.77e-05	0.000402	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ADCY5—osteoporosis	1.73e-05	0.000393	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PSMA2—osteoporosis	1.71e-05	0.000389	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PSMA5—osteoporosis	1.71e-05	0.000389	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ADCY5—osteoporosis	1.7e-05	0.000385	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ADCY5—osteoporosis	1.68e-05	0.000381	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SPP1—osteoporosis	1.68e-05	0.000381	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—MTHFR—osteoporosis	1.67e-05	0.00038	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GPX1—osteoporosis	1.67e-05	0.00038	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—P4HB—osteoporosis	1.67e-05	0.000378	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KL—osteoporosis	1.65e-05	0.000375	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SPP1—osteoporosis	1.64e-05	0.000373	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GAPDH—osteoporosis	1.64e-05	0.000371	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—POMC—osteoporosis	1.61e-05	0.000365	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CALCA—osteoporosis	1.6e-05	0.000362	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—RAP1A—osteoporosis	1.59e-05	0.000361	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL6R—osteoporosis	1.57e-05	0.000356	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—POMC—osteoporosis	1.56e-05	0.000353	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ADCY5—osteoporosis	1.56e-05	0.000353	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GPX1—osteoporosis	1.55e-05	0.000352	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—MTHFR—osteoporosis	1.55e-05	0.00035	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IRS2—osteoporosis	1.52e-05	0.000344	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IRS2—osteoporosis	1.49e-05	0.000337	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—LEP—osteoporosis	1.49e-05	0.000337	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—IL6—osteoporosis	1.47e-05	0.000333	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—LEP—osteoporosis	1.45e-05	0.00033	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KL—osteoporosis	1.45e-05	0.000329	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—POMC—osteoporosis	1.45e-05	0.000328	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—MTHFR—osteoporosis	1.43e-05	0.000324	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ESR1—osteoporosis	1.42e-05	0.000322	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—POMC—osteoporosis	1.41e-05	0.000321	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ESR1—osteoporosis	1.39e-05	0.000315	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL6R—osteoporosis	1.38e-05	0.000313	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—POMC—osteoporosis	1.34e-05	0.000304	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IRS1—osteoporosis	1.33e-05	0.0003	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IRS1—osteoporosis	1.3e-05	0.000294	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.29e-05	0.000293	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ENO1—osteoporosis	1.29e-05	0.000292	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—POMC—osteoporosis	1.28e-05	0.000289	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PSMA5—osteoporosis	1.27e-05	0.000288	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PSMA2—osteoporosis	1.27e-05	0.000288	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.25e-05	0.000284	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—POMC—osteoporosis	1.25e-05	0.000283	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6R—osteoporosis	1.24e-05	0.000282	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—POMC—osteoporosis	1.24e-05	0.00028	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IGF1—osteoporosis	1.23e-05	0.000278	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6R—osteoporosis	1.22e-05	0.000276	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IGF1—osteoporosis	1.2e-05	0.000273	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MYC—osteoporosis	1.15e-05	0.000262	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TGFB1—osteoporosis	1.15e-05	0.000261	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—POMC—osteoporosis	1.14e-05	0.000259	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.14e-05	0.000258	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.13e-05	0.000257	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—LEP—osteoporosis	1.11e-05	0.000251	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SPP1—osteoporosis	1.1e-05	0.000249	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.06e-05	0.00024	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP19A1—osteoporosis	1.03e-05	0.000233	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IRS2—osteoporosis	9.94e-06	0.000225	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IRS1—osteoporosis	9.88e-06	0.000224	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—LEP—osteoporosis	9.73e-06	0.000221	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—POMC—osteoporosis	9.52e-06	0.000216	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL6—osteoporosis	9.39e-06	0.000213	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ESR1—osteoporosis	9.29e-06	0.000211	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6R—osteoporosis	9.29e-06	0.000211	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL6—osteoporosis	9.19e-06	0.000208	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF1—osteoporosis	9.16e-06	0.000208	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IRS1—osteoporosis	8.68e-06	0.000197	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL6—osteoporosis	8.67e-06	0.000197	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ADCY5—osteoporosis	8.41e-06	0.000191	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GPX1—osteoporosis	8.38e-06	0.00019	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—POMC—osteoporosis	8.36e-06	0.000189	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6R—osteoporosis	8.15e-06	0.000185	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF1—osteoporosis	8.04e-06	0.000182	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MTHFR—osteoporosis	7.74e-06	0.000175	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MYC—osteoporosis	7.38e-06	0.000167	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TGFB1—osteoporosis	7.36e-06	0.000167	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MYC—osteoporosis	7.22e-06	0.000164	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TGFB1—osteoporosis	7.21e-06	0.000163	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL6—osteoporosis	7e-06	0.000159	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—POMC—osteoporosis	6.19e-06	0.00014	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL6—osteoporosis	6.15e-06	0.000139	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6—osteoporosis	5.55e-06	0.000126	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MYC—osteoporosis	5.5e-06	0.000125	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TGFB1—osteoporosis	5.49e-06	0.000124	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6—osteoporosis	5.43e-06	0.000123	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MYC—osteoporosis	4.83e-06	0.00011	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TGFB1—osteoporosis	4.82e-06	0.000109	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6—osteoporosis	4.14e-06	9.38e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6—osteoporosis	3.63e-06	8.23e-05	CbGpPWpGaD
